MCID: BLD048
MIFTS: 49

Bladder Transitional Cell Carcinoma malady

Cancer diseases, Nephrological diseases categories
Download this MalaCard

Summaries for Bladder Transitional Cell Carcinoma

About this section
Sources:
33MalaCards
See all sources

Fully expand this MalaCard
MalaCards: Bladder Transitional Cell Carcinoma, also known as transitional cell carcinoma of bladder, is related to transitional cell carcinoma and papilloma. An important gene associated with Bladder Transitional Cell Carcinoma is NOTCH1 (notch 1), and among its related pathways are Notch signaling pathway and Pre-NOTCH Expression and Processing. The compounds acnu and 10-hydroxycamptothecin have been mentioned in the context of this disorder. Affiliated tissues include prostate, endothelial and lymph node, and related mouse phenotypes are pigmentation and hearing/vestibular/ear.

Aliases & Classifications for Bladder Transitional Cell Carcinoma

About this section
Sources:
8Disease Ontology, 10DISEASES, 45Novoseek, 62UMLS, 58SNOMED-CT, 40NCIt
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Cancer diseases
Anatomical: Nephrological diseases


Aliases & Descriptions:

bladder transitional cell carcinoma 8 10
transitional cell carcinoma of bladder 8 62
urinary bladder urothelial carcinoma 8
carcinoma transitional cell bladder 45


External Ids:

Disease Ontology8 DOID:4006
NCIt40 C39851

Related Diseases for Bladder Transitional Cell Carcinoma

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Bladder Transitional Cell Carcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show all 47)
idRelated DiseaseScoreTop Affiliating Genes
1transitional cell carcinoma32.1CGB, TP53, CDKN1A
2papilloma30.4CDKN1A, TP53
3adenocarcinoma30.1TP53, CDKN1A, MMP10, NOTCH1, CGB, PRSS8
4invasive bladder transitional cell carcinoma10.7
5prostatitis10.4
6endotheliitis10.4
7large cell carcinoma10.3
8pleomorphic carcinoma10.3
9small cell carcinoma10.3
10sarcomatoid transitional cell carcinoma10.3
11bladder urothelial papillary carcinoma10.3
12amyloidosis10.3
13inverted papilloma10.3
14cervicitis10.2
15herpes simplex10.2
16prostate adenocarcinoma10.2
17li-fraumeni syndrome10.1CDKN1A, TP53
18breast cancer, invasive ductal10.1TP53, CDKN1A
19thyroid cancer, anaplastic10.1CDKN1A, TP53
20serotonin syndrome10.1CGB, NOTCH1
21laryngeal squamous cell carcinoma10.0TP53, CDKN1A
22oligodendroglioma10.0TP53, CDKN1A
23malignant glioma10.0CDKN1A, NOTCH1, TP53
24cervical cancer10.0TP53, NOTCH1, CDKN1A
25endometrial carcinoma10.0CDKN1A, FGF3, TP53
26bladder carcinoma10.0CGB, TP53, CDKN1A
27colorectal cancer10.0FGF3, CDKN1A, TP53
28retinoblastoma10.0CDKN1A, FGF3, TP53
29cholangiocarcinoma10.0TP53, CGB
30colon cancer10.0TP53, FGF3, CDKN1A
31oral cancer10.0CDKN1A, TP53
32pancreatic cancer10.0NOTCH1, TP53, CDKN1A
33brain cancer10.0TP53, NOTCH1, CGB, CDKN1A
34stomach cancer10.0FGF3, CDKN1A, TP53
35hepatocellular carcinoma10.0TP53, NOTCH1, FGF3, CDKN1A
36osteosarcoma10.0CGB, NOTCH1, CDKN1A, TP53
37squamous cell carcinoma of the head and neck10.0CDKN1A, MMP10, TP53
38prostate cancer10.0CGB, CDKN1A, PRSS8
39lung cancer10.0FGF3, TP53, CDKN1A, CGB
40leukemia10.0CGB, NOTCH1, CDKN1A, TP53
41burkitt's lymphoma9.9TP53, MMP10, CDKN1A, NOTCH1
42breast cancer9.9CDKN1A, CGB, NOTCH1, FGF3, TP53
43melanoma9.9TP53, NOTCH1, CDKN1A, CGB, FGF3
44non-small cell lung carcinoma9.9CDKN1A, MMP10, CGB, TP53
45adenoma9.9NR2F1, TP53, CDKN1A, FGF3, CGB
46ovarian cancer9.9CDKN1A, PRSS8, NOTCH1, CGB, FGF3, TP53
47tongue squamous cell carcinoma9.9CDKN1A, FGF3, CGB, NOTCH1, MMP10, TP53

Graphical network of the top 20 diseases related to Bladder Transitional Cell Carcinoma:



Diseases related to bladder transitional cell carcinoma

Symptoms for Bladder Transitional Cell Carcinoma

About this section

Drugs & Therapeutics for Bladder Transitional Cell Carcinoma

About this section
Sources:
42NIH Clinical Center, 6ClinicalTrials, 62UMLS, 41NDF-RT
See all sources

Drug clinical trials:

Search ClinicalTrials for Bladder Transitional Cell Carcinoma

Search NIH Clinical Center for Bladder Transitional Cell Carcinoma

Genetic Tests for Bladder Transitional Cell Carcinoma

About this section

Anatomical Context for Bladder Transitional Cell Carcinoma

About this section
Sources:
33MalaCards
See all sources

MalaCards organs/tissues related to Bladder Transitional Cell Carcinoma:

33
Prostate, Endothelial, Lymph node, Bone, Adipocyte, Kidney, Lung, Dentritic cells

Animal Models for Bladder Transitional Cell Carcinoma or affiliated genes

About this section
Sources:
37MGI
See all sources

MGI Mouse Phenotypes related to Bladder Transitional Cell Carcinoma:

37 (show all 11)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00011869.3NOTCH1, NR2F1, TP53
2MP:00053779.0NR2F1, NOTCH1, CDKN1A, FGF3
3MP:00053718.8TP53, PRSS8, CDKN1A, FGF3
4MP:00053918.6TP53, NR2F1, NOTCH1, CDKN1A
5MP:00053808.5TP53, PRSS8, NOTCH1, CDKN1A, FGF3
6MP:00053888.5CDKN1A, NOTCH1, MMP10, TP53
7MP:00053878.0CDKN1A, NOTCH1, PRSS8, MMP10, TP53
8MP:00030128.0FGF3, CDKN1A, NR2F1, PRSS8, HEPACAM, TP53
9MP:00036318.0TP53, PRSS8, NR2F1, NOTCH1, CDKN1A, FGF3
10MP:00107687.8TP53, PRSS8, NR2F1, NOTCH1, CDKN1A, FGF3
11MP:00028737.6TP53, MMP10, PRSS8, NR2F1, NOTCH1, FGF3

Publications for Bladder Transitional Cell Carcinoma

About this section
Sources:
52PubMed
See all sources

Articles related to Bladder Transitional Cell Carcinoma:

(show top 50)    (show all 159)
idTitleAuthorsYear
1
Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma. (23613251)
2013
2
Apoptosis of bladder transitional cell carcinoma T24 cells induced by adenovirus-mediated inducible nitric oxide synthase gene transfection. (24255584)
2013
3
Comparing intra-arterial chemotherapy combined with intravesical chemotherapy versus intravesical chemotherapy alone: a randomised prospective pilot study for T1G3 bladder transitional cell carcinoma after bladder-preserving surgery. (23511989)
2013
4
CXCR4 Expression in Bladder Transitional Cell Carcinoma and Its Relationship with Clinicopathological Features. (23988662)
2013
5
Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma. (24196429)
2013
6
Bladder transitional cell carcinoma and BK virus in a young kidney transplant recipient. (23231013)
2013
7
Redox- and expression-proteomic analysis of plasma biomarkers in bladder transitional cell carcinoma. (23090237)
2012
8
Recurrence patterns of bladder transitional cell carcinoma after radical cystectomy. (22893727)
2012
9
Metastatic bladder transitional cell carcinoma presenting as a vascularised cutaneous right arm lesion. (21779951)
2012
10
Proteomics research on muscle-invasive bladder transitional cell carcinoma. (21645413)
2011
11
Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men. (21046286)
2011
12
Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma. (21672320)
2011
13
Reciprocal correlation between the expression of cyclooxygenase-2 and E-cadherin in human bladder transitional cell carcinomas. (20582552)
2010
14
Differences in shotgun protein expression profile between superficial bladder transitional cell carcinoma and normal urothelium. (18818109)
2009
15
Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin. (18538698)
2008
16
Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. (18699961)
2008
17
Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma. (18410436)
2008
18
The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy. (19077398)
2008
19
E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma. (18931551)
2008
20
Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma. (17222615)
2007
21
Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma. (17302565)
2007
22
Consistency of microstaging pT1 bladder transitional cell carcinoma. (17322343)
2007
23
Expression of apoptosis inhibitor gene Livin in bladder transitional cell carcinoma and clinical implication thereof]. (17565859)
2007
24
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group. (17011058)
2006
25
Differential gene expression profiling in aggressive bladder transitional cell carcinoma compared to the adjacent microscopically normal urothelium by microdissection-SMART cDNA PCR-SSH. (16357518)
2006
26
Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma. (16784833)
2006
27
Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography. (15989448)
2005
28
Heat shock protein 70 expression in relation to apoptosis in primary bladder transitional cell carcinoma. (16438908)
2005
29
Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. (15677544)
2005
30
Bladder transitional cell carcinoma: correlation of contrast enhancement on computed tomography with histological grade and tumour angiogenesis. (15664576)
2005
31
Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1. (15492256)
2004
32
Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. (14981105)
2004
33
Evaluation of chromosome 8 and 11 aneuploidies in washings and biopsy materials of bladder transitional cell carcinoma. (12660029)
2003
34
Significance of activated matrix metalloproteinase 2 (MMP2) in progression of bladder transitional cell carcinoma]. (12948424)
2003
35
Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression. (12651606)
2003
36
Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray. (12644218)
2002
37
High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma. (12036448)
2002
38
Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma. (11696726)
2001
39
Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract. (11490207)
2001
40
The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expression and apoptosis in human bladder transitional cell carcinoma. (11490306)
2001
41
Correlative expression of glutathione S-transferase-pi and multidrug resistance associated protein in bladder transitional cell carcinoma. (12840920)
2000
42
Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens. (11108659)
2000
43
Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. (10499628)
1999
44
The loss of expression of transforming growth factor-beta receptors correlates with the histopathologic tumor grade in bladder transitional cell carcinoma patients. (10333714)
1999
45
p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage. (9187909)
1997
46
Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma. (1377428)
1992
47
Interferon-alpha can alter the lytic susceptibility of murine bladder transitional cell carcinoma (MBT-2) by their original poor specific cytotoxic tumor infiltrating lymphocytes. (1732635)
1992
48
Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13. (2759734)
1989
49
Comparison of cell-associated and soluble galactosyltransferase isoenzymes from a human bladder transitional cell carcinoma line. (3105874)
1987
50
Galactosyl transferase activity in rat bladder transitional cell carcinoma lines and in exfoliated cells in urine during carcinogenesis and reversible hyperplasia. (6778604)
1980

Variations for Bladder Transitional Cell Carcinoma

About this section

Expression for genes affiliated with Bladder Transitional Cell Carcinoma

About this section
Sources:
2BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Bladder Transitional Cell Carcinoma

Search GEO for disease gene expression data for Bladder Transitional Cell Carcinoma.

Pathways for genes affiliated with Bladder Transitional Cell Carcinoma

About this section
Sources:
50PathCards, 30KEGG, 38NCBI BioSystems Database, 55Reactome, 54R&D Systems, 53QIAGEN, 60Thomson Reuters, 12EMD Millipore
See all sources

Pathways related to Bladder Transitional Cell Carcinoma according to GeneCards/GeneDecks:

(show all 24)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
Notch signaling pathway38
9.8CDKN1A, NOTCH1
2
Show member pathways
9.8NOTCH1, TP53
39.8CDKN1A, TP53
4
Show member pathways
ATM Signaling Pathway38
9.8CDKN1A, TP53
5
Show member pathways
9.8CDKN1A, TP53
69.8CDKN1A, TP53
79.8CDKN1A, TP53
8
Show member pathways
9.8CDKN1A, TP53
99.8CDKN1A, TP53
109.8CDKN1A, TP53
11
Show member pathways
9.8CDKN1A, TP53
129.8CDKN1A, TP53
139.8TP53, CDKN1A
14
Show member pathways
Apoptosis and survival Apoptotic TNF family pathways60
9.8TP53, CDKN1A
159.8TP53, CDKN1A
169.8TP53, CDKN1A
179.8TP53, CDKN1A
189.6CGB, TP53
199.4CDKN1A, NOTCH1, TP53
209.3FGF3, CDKN1A, TP53
21
Show member pathways
Signaling Pathways in Glioblastoma38
9.3FGF3, CDKN1A, TP53
229.3TP53, CDKN1A, FGF3
239.3FGF3, CDKN1A, TP53
24
Show member pathways
8.2TP53, MMP10, NOTCH1, CDKN1A, FGF3

Compounds for genes affiliated with Bladder Transitional Cell Carcinoma

About this section
Sources:
45Novoseek, 11DrugBank, 61Tocris Bioscience, 24HMDB, 51PharmGKB, 29IUPHAR
See all sources

Compounds related to Bladder Transitional Cell Carcinoma according to GeneCards/GeneDecks:

(show all 39)
idCompoundScoreTop Affiliating Genes
1acnu4510.2CDKN1A, TP53
210-hydroxycamptothecin4510.2CDKN1A, TP53
37-hydroxystaurosporine45 1111.2TP53, CDKN1A
4tomudex4510.2TP53, CDKN1A
5hpvs4510.2CDKN1A, TP53
63,3-diindolylmethane4510.1CDKN1A, TP53
7olomoucine45 1111.1TP53, CDKN1A
8temozolomide45 1111.1CDKN1A, TP53
9hmba4510.1CDKN1A, TP53
10taxane4510.1CDKN1A, TP53
11noxa4510.1CDKN1A, TP53
12cd 4374510.1CDKN1A, TP53
13aphidicolin4510.1CDKN1A, TP53
14indole-3-carbinol4510.1CDKN1A, TP53
15sulindac45 1111.1CDKN1A, TP53
16depsipeptide4510.0CDKN1A, TP53
17methylmethanesulfonate4510.0CDKN1A, TP53
18suberoylanilide hydroxamic acid4510.0TP53, CDKN1A
19n-(4-hydroxyphenyl)retinamide4510.0CDKN1A, TP53
202-methoxyestradiol45 61 2412.0CDKN1A, TP53
21roscovitine4510.0TP53, CDKN1A
22benzo(a)pyrene459.9CDKN1A, TP53
23leptomycin b45 6110.9CDKN1A, TP53
24oxaliplatin45 51 1111.9TP53, CDKN1A
25flavopiridol45 1110.8CDKN1A, TP53
26ly294002459.7TP53, NOTCH1, CDKN1A
27doxorubicin45 51 1111.7TP53, NOTCH1, CDKN1A
28bortezomib45 51 1111.7TP53, CDKN1A
29etoposide45 51 61 1112.6TP53, CDKN1A, CGB
30bleomycin45 1110.6CGB, TP53
31pdtc459.5CDKN1A, TP53
32retinoic acid45 2410.2TP53, NR2F1, NOTCH1, CDKN1A
33cisplatin45 51 61 1112.2CGB, CDKN1A, TP53
34matrigel459.2MMP10, NOTCH1, CGB
35progesterone45 29 61 24 1113.1TP53, NR2F1, CDKN1A, CGB
36estrogen458.8TP53, NR2F1, NOTCH1, CDKN1A, CGB
37serine458.4TP53, MMP10, PRSS8, NOTCH1, CDKN1A
38oligonucleotide458.4TP53, MMP10, NR2F1, CDKN1A, FGF3
39vegf458.1FGF3, CGB, CDKN1A, NOTCH1, MMP10, TP53

GO Terms for genes affiliated with Bladder Transitional Cell Carcinoma

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Bladder Transitional Cell Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1nucleoplasmGO:0056548.9CDKN1A, NOTCH1, NR2F1, TP53
2extracellular regionGO:0055767.4FGF3, CGB, NOTCH1, PRSS8, MMP10

Biological processes related to Bladder Transitional Cell Carcinoma according to GeneCards/GeneDecks:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1mitotic cell cycle arrestGO:07185010.0CDKN1A, TP53
2cellular response to ionizing radiationGO:0714799.9TP53, CDKN1A
3positive regulation of reactive oxygen species metabolic processGO:20003799.9CDKN1A, TP53
4intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorGO:0427719.9CDKN1A, TP53
5cellular protein localizationGO:0346139.8TP53, HEPACAM
6Ras protein signal transductionGO:0072659.8CDKN1A, TP53
7intrinsic apoptotic signaling pathwayGO:0971939.7TP53, CDKN1A
8cell cycle arrestGO:0070509.5CDKN1A, HEPACAM, TP53
9DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestGO:0069779.5CDKN1A, TP53
10negative regulation of cell proliferationGO:0082859.4CDKN1A, NOTCH1, TP53

Products for genes affiliated with Bladder Transitional Cell Carcinoma

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Bladder Transitional Cell Carcinoma

About this section
4CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
52PubMed
53QIAGEN
59SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet